by Rod Raynovich | Dec 13, 2010 | Energy, Weather//Ski Reports-Western US
West Coast Weather: Wet and Warm Changes are coming in the West as the high pressure breaks down bringing in storms this week and next weekend. Weather Geek : TahoeLoco.com The storm track will remain to the North of the Sierras mid -week with a bigger storm from the...
by Rod Raynovich | Dec 10, 2010 | 2023-24 Life Science Portfolios, BIOgraph
Tools and Diagnostic stocks are having a good day perhaps sparked by the BeckmanCoulter (BEC) announcement that it is being put up for sale. The BEC stock is up 27% to $72.68.You could have bought Beckman only 3 months ago at $45 after resignation of the CEO and a...
by Rod Raynovich | Dec 9, 2010 | Energy, Weather//Ski Reports-Western US
After an inventory report the bulls paused off intermediate top in the 4.60 range then headed for the sidelines as January Futures were off 13 cents to $4.47. Support is $4.40. The decline in storage was -89 bcf from the previous week not enough to spark buying....
by Rod Raynovich | Dec 6, 2010 | 2023-24 Life Science Portfolios, BIOgraph
Life Science ETF’s: Strategy and Composition There are several ETF’s with biotech and drug positions but the three that are large, liquid and better known with asset values are : First Trust Amex Arca Biotech Index (FBT,$166M) , iShares Nasdaq...
by Rod Raynovich | Dec 6, 2010 | Energy, Macro, Weather//Ski Reports-Western US
Nat Gas Approaches Breakout at $4.50 Cold weather is forecasted for the NE and SE for the next 10 days giving a boost to nat gas prices reaching a five day high near $4.50 today. November price highs are in the $4.52 area which could spark a bull camp move to $4.92....
by Rod Raynovich | Dec 2, 2010 | BIOgraph
Contrarian Call -Look at the Drug Stocks The healthcare sector has lagged the market in 2010 down about 1.34% compared to the S&P up about 9%. The large cap drug sector has done worse down 4.3%. Investors are drawn to more dynamic growth sectors in 2010: energy,...
by Rod Raynovich | Dec 1, 2010 | 2023-24 Life Science Portfolios, BIOgraph
SeraCare Reports 40% Increase in Net Income Over Prior Year SeraCare (SRLS) executed six consecutive quarters of successful growth with revenue growth of 13% to $50.4 M for the fiscal year ending SEP 30, compared to revenues of $44.4M year in 2009. Net Income was...